Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics Europska Unija - slovenski - EMA (European Medicines Agency)

prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics

novartis vaccines and diagnostics s.r.l. - površinski antigeni virusa influence (hemaglutinin in nevraminidaza) seva a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - cepiva - aktivna imunizacija proti podtipu h5n1 virusa influenca a. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

Zoonotic Influenza Vaccine Seqirus Europska Unija - slovenski - EMA (European Medicines Agency)

zoonotic influenza vaccine seqirus

seqirus s.r.l.  - zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted), influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/turkey/turkey/1/05 (h5n1)-like strain (nibrg-23) - influenza a virus, h5n1 subtype - cepiva - active immunisation against h5 subtype of influenza a virus.

Bexsero Europska Unija - slovenski - EMA (European Medicines Agency)

bexsero

gsk vaccines s.r.l. - zunanjo membrano semenskih mešičkov iz neisseria meningitidis skupina b (sev nz 98/254), rekombinantne neisseria meningitidis skupina b fhbp fuzijski protein, rekombinantne neisseria meningitidis skupina b nada beljakovin, rekombinantne neisseria meningitidis skupina b nhba fuzijski protein - meningitis, meningokokni - meningococcal cepiva - aktivna imunizacija proti invazivni bolezni, ki jo povzročajo sevi neisseria meningitidis serogroup-b.

Carvykti Europska Unija - slovenski - EMA (European Medicines Agency)

carvykti

janssen-cilag international nv - ciltacabtagene autoleucel - multiple myeloma - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Amikacin Kabi 5 mg/ml raztopina za infundiranje Slovenija - slovenski - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

amikacin kabi 5 mg/ml raztopina za infundiranje

amikacin - raztopina za infundiranje - amikacin 5 mg / 1 ml - amikacin

Amikacin Kabi 5 mg/ml raztopina za infundiranje Slovenija - slovenski - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

amikacin kabi 5 mg/ml raztopina za infundiranje

amikacin - raztopina za infundiranje - amikacin 5 mg / 1 ml - amikacin

Amikacin Kabi 5 mg/ml raztopina za infundiranje Slovenija - slovenski - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

amikacin kabi 5 mg/ml raztopina za infundiranje

amikacin - raztopina za infundiranje - amikacin 5 mg / 1 ml - amikacin

Glukoza Krka 50 mg/ml raztopina za infundiranje Slovenija - slovenski - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

glukoza krka 50 mg/ml raztopina za infundiranje

raztopina za infundiranje - ogljikovi hidrati

Bivacyn 3.500 i.e./500 i.e. v 1 g mazilo Slovenija - slovenski - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

bivacyn 3.500 i.e./500 i.e. v 1 g mazilo

lek d.d. - bacitracin; neomicin - mazilo - bacitracin 500 i.e. / 1 g  neomicin3500 i.e. / 1 g; neomicin 3500 i.e. / 1 g - neomicin

Bivacyn 3.500 i.e./250 i.e. v 1 g mazilo za oko Slovenija - slovenski - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

bivacyn 3.500 i.e./250 i.e. v 1 g mazilo za oko

lek d.d. - bacitracin; neomicin - mazilo za oko - bacitracin 250 i.e. / 1 g  neomicin3500 i.e. / 1 g; neomicin 3500 i.e. / 1 g - kombinacije različnih antibiotikov